The company from Novosibirsk, Russia, is specializing in production and application of liquid probiotics in therapy of various diseases (intestine malfunctions, allergy), which improve considerably the life quality of patients with different pathologies. The company is looking for partners in the EU for cooperation in the framework of a distribution services agreement.
The Russian company from Novosibirsk with a great experience in application of liquid probiotics in therapy of various diseases, discovered that they improve considerably the psychosomatic state of cancer patients undergoing chemotherapy or radiation therapy. he company has a great amount of experience in treating patients with probiotics, including publications and developed guidelines. The company was established in 1993 and has other dairy probiotic products on the markets of Russia and China. The company is building new production premises in Russia due to high demand for product. It is known that radiotherapy and chemotherapy are very destructive, toxic and act nonspecifically to all fast-growing cells, including blood cells, the immune cells of the gut and useful microorganisms. Side effects of chemotherapy and radiation therapy are sometimes so strong that many patients have to refuse further treatment because of severe intoxication, serious malfunctions of gastrointestinal tract and liver. Traditionally, the problem is solved by dieting. In case of serious health deterioration of a patient, treatment is postponed until the normalization of condition. The company has developed a technology for production of bioproduct with a high concentration of live active bifidus bacteria and lacto-propionic acid bacteria (probiotics) for the treatment of dysbacteriosis, essential hypertension, vascular abnormalities, diabetes and other endocrine pathologies, for the treatment of patients after chemotherapy or radiation therapy. The bioproduct is a milk drink with a pleasant taste. Bioproducts based on liquid probiotics help to cleanse the body of endotoxins generated during aggressive cancer therapy, ensure recovery of bowel and liver, and normalize immune responses. Thereby, the side effects of chemotherapy and radiation therapy are smoothed, the patients feel better, full antitumor treatment continues without interruption. Long-term observations of the application of liquid probiotic in the rehabilitation of patients undergoing chemo- or radiation therapy clearly demonstrate that the drink intake during and between courses of chemotherapy or radiation therapy significantly improves the psychosomatic condition of patients. Meanwhile the product is not limited for use by clinical patients. It can be consumed with no limitations as a functional food product for improvement of life quality starting with 3 month old. The effectiveness of the company's products has been proven by numerous clinical trials in leading clinics of Russia. Similar specialized drugs reducing the side effects of cancer treatment and quality of life of cancer patients are not currently presented at the market. The company is looking for partners for distribution services agreement. Partner can be a trading company working with pharmacies, mass market, clinics, medical institutions. Within the framework of the distribution services agreement the company will supply the probiotic products to the partner for distribution in the specific country or countries. The company is ready to assist and share the experience of clinical practice as well as the experience of promoting the product to Russian and Asian markets. The partner will purchase, promote and sell the product to the EU or one of the European countries. The expected result from cooperation is promotion of the product to the new market, increase in volume of sales.
Innovations and advantages
- The main innovation is the use of liquid probiotics for reducing the side effects of chemotherapy and radiation therapy and improvement of the quality of life of cancer patients and patients with different pathologies (allergy, intestines malfunctions, etc.). - The traditional disadvantage of products with probiotics is a short shelf life. The innovative production technology allows maintaining high activity of live beneficial bacteria within the whole shelf-life of the product (2.5-3 months). The high concentration of bifidus bacteria in liquid probiotics (109 CFU (colony-forming units) in 1 ml) provides a higher clinical efficacy (up to 5-6 times), as compared to conventional dry probiotics. - Live probiotic microorganisms are active and take effect from the moment of intake. For comparison, the bacteria from conventional dry probiotics usually require 8-10 hours to get activated. - Ease of use: the liquid form of the drug ensures comfort in use even for kids from 3 months old. - The proposed products are manufactured only of natural milk and special starters, without the use of genetically modified ingredients, thickeners, dyes, preservatives. The product has a pleasant taste.
08001002 Food Additives/Ingredients/Functional Food
Market application codes
07003002 Health food
Comments, number and date of patent
The company has a number of patents in Russia as well as several registered trademarks.
Area of partner's activity
Type of company: SME. Field of activity: wholesale and retail, including work with pharmacies, medical and clinical institutions. Partner’s role: promotion and sales of the product under distribution services agreement.